These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30324481)

  • 1. ASO Author Reflections: Hematological Biomarkers of Survival in Cutaneous Melanoma.
    Robinson AV; Peach H; Wade RG
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):910-911. PubMed ID: 30324481
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas.
    Thompson JF; Scolyer RA; Lo SN
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):918-919. PubMed ID: 30414034
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified.
    Francken AB; Hoekstra-Weebers JEHM; Deckers E; Hoekstra HJ
    Ann Surg Oncol; 2020 May; 27(5):1418-1419. PubMed ID: 31482389
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Cutaneous Melanoma as Model System for the Obesity Paradox in Cancer.
    Harrell Shreckengost C; Lowe MC
    Ann Surg Oncol; 2021 Oct; 28(11):6152-6153. PubMed ID: 33748893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study.
    Wade RG; Robinson AV; Lo MCI; Keeble C; Marples M; Dewar DJ; Moncrieff MDS; Peach H
    Ann Surg Oncol; 2018 Oct; 25(11):3341-3349. PubMed ID: 30066226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASO Author Reflections: Effects of the Updated AJCC Classification for Patients with Stage III Melanoma.
    Katsarelias D; Isaksson K; Olofsson Bagge R
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):713-714. PubMed ID: 31468215
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Factors that Predict Performance of Sentinel Lymph Node Biopsy and the Association with Improved Survival for Melanoma Patients Who Have Nodal Staging.
    Murtha TD; Han D
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):904-905. PubMed ID: 30302646
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Is There a Relationship Between TIL and Regression in Melanoma?
    Morrison S; Zager JS; Vetto J
    Ann Surg Oncol; 2022 May; 29(5):2867-2868. PubMed ID: 35059884
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Sentinel Lymph Node Biopsy Trend in Melanoma: The More the Merrier.
    El Sharouni MA; Witkamp A; Sigurdsson V; van Diest PJ
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):723-724. PubMed ID: 31489554
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Staging System for Mucosal Melanoma: A Proposal to Fill a Gap.
    Cui C; Lian B; Guo J
    Ann Surg Oncol; 2022 Aug; 29(8):5235-5236. PubMed ID: 35412206
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Primary Site Should Be Regarded as One Important Factor for Risk Stratification in Acral Melanoma.
    Wei X; Si L; Guo J
    Ann Surg Oncol; 2020 Sep; 27(9):3486-3487. PubMed ID: 32248373
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Implementing a Program of Talimogene laherparepvec.
    Collichio F
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):920-921. PubMed ID: 30421049
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Lower Guideline Concordance and Decreased Overall Survival for Melanoma Patients at Minority-Serving Hospitals: How Can We Do Better?
    Greene AC; Wong WG; Pameijer CR; Shen C
    Ann Surg Oncol; 2023 Jun; 30(6):3646-3647. PubMed ID: 36997820
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Melanoma Patients with a Local Recurrence or In-Transit Metastasis: Sentinel Node Biopsy to Identify Those at Highest Risk of Metastases and Death.
    Nijhuis AAG; Nieweg OE
    Ann Surg Oncol; 2020 Feb; 27(2):569-570. PubMed ID: 31667723
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Challenges to Achieving Consistent Nodal Surveillance with Ultrasound in Melanoma.
    Montgomery KB; Broman KK
    Ann Surg Oncol; 2022 Sep; 29(9):5969-5970. PubMed ID: 35532829
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: The Landmark Series: Neoadjuvant Systemic Therapy (NAST) for Stage 3 Melanoma Patients: A Potential Paradigm Shift in Management.
    van Akkooi ACJ; Spillane AJ
    Ann Surg Oncol; 2020 Jul; 27(7):2201-2202. PubMed ID: 32382889
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Subungual Melanomas of the Hand Present Diagnostic and Therapeutic Challenges.
    Chakera AH; Thompson JF
    Ann Surg Oncol; 2019 Apr; 26(4):1044-1045. PubMed ID: 30719637
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Comparison of Prognostic Impact of Various Systemic Inflammatory Markers for Stage II/III Colon Cancer.
    Suzuki S; Akiyoshi T
    Ann Surg Oncol; 2020 Mar; 27(3):853-854. PubMed ID: 31720932
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma.
    Chasseuil E; Saint-Jean M; Chasseuil H; Peuvrel L; Quéreux G; Nguyen JM; Gaultier A; Varey E; Khammari A; Dréno B
    Acta Derm Venereol; 2018 Apr; 98(4):406-410. PubMed ID: 29327065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Survival for Stage III Melanoma-Where Do We Stand in the Current Landscape of Melanoma Therapies?
    Song Y; Karakousis GC
    Ann Surg Oncol; 2019 Dec; 26(13):4631-4632. PubMed ID: 31576473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.